Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Risk of Hyperbilirubinemia in Term Newborns After Placental Transfusion: A Randomized-blinded Controlled Trial

NCT02625688 is registered in ClinicalTrials.gov with Princess Anna Mazowiecka Hospital, Warsaw, Poland as lead sponsor.

NCT NCT02625688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02625688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Risk of Hyperbilirubinemia in Term Newborns After Placental Transfusion: A Randomized-blinded Controlled Trial
Lead sponsor
Princess Anna Mazowiecka Hospital, Warsaw, Poland
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2013
Completion date
December 31, 2016
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

jaundice neonatal